{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:42:08Z","timestamp":1790286128726,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T00:00:00Z","timestamp":1681776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T00:00:00Z","timestamp":1681776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital, Linkou","doi-asserted-by":"publisher","award":["CLRPG3D0049"],"award-info":[{"award-number":["CLRPG3D0049"]}],"id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s10620-023-07943-z","type":"journal-article","created":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T06:02:39Z","timestamp":1681797759000},"page":"2747-2756","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prognostic Effects of Liver Fibrosis and Steatosis Determined Using Transient Elastography in Patients with Chronic Hepatitis B or C"],"prefix":"10.1007","volume":"68","author":[{"given":"Chun-Li","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Hao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor Chien-Chia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Ling","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Tung","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0462-2344","authenticated-orcid":false,"given":"Shang-Hung","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,18]]},"reference":[{"key":"7943_CR1","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12880-022-00777-7","volume":"22","author":"S Kavak","year":"2022","unstructured":"Kavak S, Kaya S, Senol A, Sogutcu N. Evaluation of liver fibrosis in chronic hepatitis B patients with 2D shear wave elastography with propagation map guidance: a single-centre study. BMC Med Imaging. 2022;22:50.","journal-title":"BMC Med Imaging."},{"key":"7943_CR2","doi-asserted-by":"publisher","first-page":"6663","DOI":"10.3748\/wjg.v22.i29.6663","volume":"22","author":"DW Zeng","year":"2016","unstructured":"Zeng DW, Dong J, Liu YR, Jiang JJ, Zhu YY. Noninvasive models for assessment of liver fibrosis in patients with chronic hepatitis B virus infection. World J Gastroenterol. 2016;22:6663\u20136672.","journal-title":"World J Gastroenterol."},{"key":"7943_CR3","doi-asserted-by":"publisher","first-page":"11033","DOI":"10.3748\/wjg.v20.i32.11033","volume":"20","author":"G Sebastiani","year":"2014","unstructured":"Sebastiani G, Gkouvatsos K, Pantopoulos K. Chronic hepatitis C and liver fibrosis. World J Gastroenterol. 2014;20:11033\u201311053.","journal-title":"World J Gastroenterol."},{"key":"7943_CR4","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.cmi.2016.09.017","volume":"22","author":"I Carmona","year":"2016","unstructured":"Carmona I, Cordero P, Ampuero J, Rojas A, Romero-G\u00f3mez M. Role of assessing liver fibrosis in management of chronic hepatitis C virus infection. Clin Microbiol Infect. 2016;22:839\u2013845.","journal-title":"Clin Microbiol Infect."},{"key":"7943_CR5","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.jhep.2007.07.006","volume":"47","author":"ZD Goodman","year":"2007","unstructured":"Goodman ZD. Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J Hepatol. 2007;47:598\u2013607.","journal-title":"J Hepatol."},{"key":"7943_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12072-016-9760-3","volume":"11","author":"G Shiha","year":"2017","unstructured":"Shiha G, Ibrahim A, Helmy A et al. Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update. Hepatol Int. 2017;11:1\u201330.","journal-title":"Hepatol Int."},{"key":"7943_CR7","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1111\/liv.12240","volume":"33","author":"S Bota","year":"2013","unstructured":"Bota S, Herkner H, Sporea I et al. Meta-analysis: ARFI elastography versus transient elastography for the evaluation of liver fibrosis. Liver Int. 2013;33:1138\u20131147.","journal-title":"Liver Int."},{"key":"7943_CR8","doi-asserted-by":"publisher","first-page":"2816","DOI":"10.1007\/s10620-020-06591-x","volume":"66","author":"JH Oh","year":"2021","unstructured":"Oh JH, Goh MJ, Park Y et al. Different performance of liver stiffness measurement according to etiology and outcome for the prediction of liver-related events. Dig Dis Sci. 2021;66:2816\u20132825. https:\/\/doi.org\/10.1007\/s10620-020-06591-x.","journal-title":"Dig Dis Sci."},{"key":"7943_CR9","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.jhep.2013.12.018","volume":"60","author":"V de L\u00e9dinghen","year":"2014","unstructured":"de L\u00e9dinghen V, Vergniol J, Capdepont M et al. Controlled attenuation parameter (CAP) for the diagnosis of steatosis: a prospective study of 5323 examinations. J Hepatol. 2014;60:1026\u20131031.","journal-title":"J Hepatol."},{"key":"7943_CR10","doi-asserted-by":"publisher","first-page":"e36676","DOI":"10.1371\/journal.pone.0036676","volume":"7","author":"SU Kim","year":"2012","unstructured":"Kim SU, Lee JH, Kim DY et al. Prediction of liver-related events using fibroscan in chronic hepatitis B patients showing advanced liver fibrosis. PLoS ONE 2012;7:e36676.","journal-title":"PLoS ONE"},{"key":"7943_CR11","doi-asserted-by":"publisher","first-page":"e0184404","DOI":"10.1371\/journal.pone.0184404","volume":"12","author":"AZ Gomez-Moreno","year":"2017","unstructured":"Gomez-Moreno AZ, Pineda-Tenor D, Jimenez-Sousa MA et al. Liver stiffness measurement predicts liver-related events in patients with chronic hepatitis C: a retrospective study. PLoS ONE 2017;12:e0184404.","journal-title":"PLoS ONE"},{"key":"7943_CR12","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1111\/apt.12307","volume":"37","author":"V de L\u00e9dinghen","year":"2013","unstructured":"de L\u00e9dinghen V, Vergniol J, Barthe C et al. Non-invasive tests for fibrosis and liver stiffness predict 5-year survival of patients chronically infected with hepatitis B virus. Aliment Pharmacol Ther. 2013;37:979\u2013988.","journal-title":"Aliment Pharmacol Ther."},{"key":"7943_CR13","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1053\/j.gastro.2011.02.058","volume":"140","author":"J Vergniol","year":"2011","unstructured":"Vergniol J, Foucher J, Terrebonne E et al. Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C. Gastroenterology. 2011;140:1970\u20131979.","journal-title":"Gastroenterology."},{"key":"7943_CR14","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1046\/j.1440-1746.2001.02407.x","volume":"16","author":"SJ Hwang","year":"2001","unstructured":"Hwang SJ, Luo JC, Chu CW et al. Hepatic steatosis in chronic hepatitis C virus infection: prevalence and clinical correlation. J Gastroenterol Hepatol. 2001;16:190\u2013195.","journal-title":"J Gastroenterol Hepatol."},{"key":"7943_CR15","first-page":"35","volume":"44","author":"LA Lesmana","year":"2012","unstructured":"Lesmana LA, Lesmana CR, Pakasi LS, Krisnuhoni E. Prevalence of hepatic steatosis in chronic hepatitis B patients and its association with disease severity. Acta Med Indones. 2012;44:35\u201339.","journal-title":"Acta Med Indones."},{"key":"7943_CR16","doi-asserted-by":"publisher","first-page":"733348","DOI":"10.3389\/fcimb.2021.733348","volume":"11","author":"Y Huang","year":"2021","unstructured":"Huang Y, Gan Q, Lai R et al. Application of fatty liver inhibition of progression algorithm and steatosis, activity, and fibrosis score to assess the impact of non-alcoholic fatty liver on untreated chronic hepatitis B patients. Front Cell Infect Microbiol. 2021;11:733348.","journal-title":"Front Cell Infect Microbiol."},{"key":"7943_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jhepr.2019.02.002","volume":"1","author":"N Peleg","year":"2019","unstructured":"Peleg N, Issachar A, Sneh Arbib O et al. Liver steatosis is a strong predictor of mortality and cancer in chronic hepatitis B regardless of viral load. JHEP Rep. 2019;1:9\u201316.","journal-title":"JHEP Rep."},{"key":"7943_CR18","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1111\/jvh.13167","volume":"26","author":"N Peleg","year":"2019","unstructured":"Peleg N, Issachar A, Sneh Arbib O et al. Liver steatosis is a major predictor of poor outcomes in chronic hepatitis C patients with sustained virological response. J Viral Hepat. 2019;26:1257\u20131265.","journal-title":"J Viral Hepat."},{"key":"7943_CR19","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1111\/jvh.13361","volume":"27","author":"SW Wong","year":"2020","unstructured":"Wong SW, Chan WK, Mohamed R. Fatty liver is associated with advanced fibrosis but does not predict adverse outcomes in patients with chronic hepatitis B. J Viral Hepat. 2020;27:1297\u20131305.","journal-title":"J Viral Hepat."},{"key":"7943_CR20","doi-asserted-by":"publisher","first-page":"e0264741","DOI":"10.1371\/journal.pone.0264741","volume":"17","author":"M Rau","year":"2022","unstructured":"Rau M, Buggisch P, Mauss S et al. Prognostic impact of steatosis in the clinical course of chronic HCV infection-results from the German Hepatitis C-Registry. PLoS ONE. 2022;17:e0264741.","journal-title":"PLoS ONE."},{"key":"7943_CR21","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.jhep.2015.04.006","volume":"63","author":"EASL-ALEH Clinical Practice Guidelines","year":"2015","unstructured":"EASL-ALEH Clinical Practice Guidelines. Non-invasive tests for evaluation of liver disease severity and prognosis. J Hepatol. 2015;63:237\u2013264.","journal-title":"J Hepatol."},{"key":"7943_CR22","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.2215\/CJN.04320510","volume":"6","author":"CH Liu","year":"2011","unstructured":"Liu CH, Liang CC, Huang KW et al. Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patients. Clin J Am Soc Nephrol. 2011;6:1057\u20131065.","journal-title":"Clin J Am Soc Nephrol."},{"key":"7943_CR23","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1053\/j.gastro.2004.11.018","volume":"128","author":"L Cast\u00e9ra","year":"2005","unstructured":"Cast\u00e9ra L, Vergniol J, Foucher J et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005;128:343\u2013350.","journal-title":"Gastroenterology."},{"key":"7943_CR24","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S2468-1253(20)30357-5","volume":"6","author":"D Petroff","year":"2021","unstructured":"Petroff D, Blank V, Newsome PN et al. Assessment of hepatic steatosis by controlled attenuation parameter using the M and XL probes: an individual patient data meta-analysis. Lancet Gastroenterol Hepatol. 2021;6:185\u2013198.","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"7943_CR25","unstructured":"Fujii H, Iwaki M, Hayashi H, et al. Clinical outcomes in biopsy-proven nonalcoholic fatty liver disease patients: a multicenter registry-based cohort study. Clin Gastroenterol Hepatol. 2022."},{"key":"7943_CR26","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1016\/j.cgh.2020.12.022","volume":"19","author":"H Lee","year":"2021","unstructured":"Lee H, Lee YH, Kim SU, Kim HC. Metabolic dysfunction-associated fatty liver disease and incident cardiovascular disease risk: a nationwide cohort study. Clin Gastroenterol Hepatol. 2021;19:2138-2147.e2110.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"7943_CR27","doi-asserted-by":"publisher","first-page":"e111912","DOI":"10.1371\/journal.pone.0111912","volume":"9","author":"KM Christiansen","year":"2014","unstructured":"Christiansen KM, M\u00f6ssner BK, Hansen JF et al. Liver stiffness measurement among patients with chronic hepatitis B and C: results from a 5-year prospective study. PLoS ONE. 2014;9:e111912.","journal-title":"PLoS ONE."},{"key":"7943_CR28","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1111\/jvh.12766","volume":"25","author":"RWH Hui","year":"2018","unstructured":"Hui RWH, Seto WK, Cheung KS et al. Inverse relationship between hepatic steatosis and hepatitis B viremia: results of a large case-control study. J Viral Hepat. 2018;25:97\u2013104.","journal-title":"J Viral Hepat."},{"key":"7943_CR29","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/s10620-012-2343-9","volume":"58","author":"CM Chu","year":"2013","unstructured":"Chu CM, Lin DY, Liaw YF. Clinical and virological characteristics post HBsAg seroclearance in hepatitis B virus carriers with hepatic steatosis versus those without. Dig Dis Sci. 2013;58:275\u2013281. https:\/\/doi.org\/10.1007\/s10620-012-2343-9.","journal-title":"Dig Dis Sci."},{"key":"7943_CR30","doi-asserted-by":"publisher","first-page":"2571","DOI":"10.1007\/s10620-014-3180-9","volume":"59","author":"MM Wang","year":"2014","unstructured":"Wang MM, Wang GS, Shen F et al. Hepatic steatosis is highly prevalent in hepatitis B patients and negatively associated with virological factors. Dig Dis Sci. 2014;59:2571\u20132579. https:\/\/doi.org\/10.1007\/s10620-014-3180-9.","journal-title":"Dig Dis Sci."},{"key":"7943_CR31","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s12072-021-10218-2","volume":"15","author":"LY Mak","year":"2021","unstructured":"Mak LY, Hui RW, Fung J et al. Reduced hepatic steatosis is associated with higher risk of hepatocellular carcinoma in chronic hepatitis B infection. Hepatol Int. 2021;15:901\u2013911.","journal-title":"Hepatol Int."},{"key":"7943_CR32","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1007\/s12072-021-10205-7","volume":"15","author":"JH Oh","year":"2021","unstructured":"Oh JH, Lee HW, Sinn DH et al. Controlled attenuation parameter value and the risk of hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy. Hepatol Int. 2021;15:892\u2013900.","journal-title":"Hepatol Int."},{"key":"7943_CR33","doi-asserted-by":"publisher","first-page":"165","DOI":"10.3851\/IMP1726","volume":"16","author":"GL Wong","year":"2011","unstructured":"Wong GL, Wong VW, Choi PC et al. On-treatment monitoring of liver fibrosis with transient elastography in chronic hepatitis B patients. Antivir Ther. 2011;16:165\u2013172.","journal-title":"Antivir Ther."},{"key":"7943_CR34","doi-asserted-by":"publisher","first-page":"11681","DOI":"10.1038\/s41598-021-91099-1","volume":"11","author":"J Piedade","year":"2021","unstructured":"Piedade J, Pereira G, Guimar\u00e3es L et al. Liver stiffness regression after sustained virological response by direct-acting antivirals reduces the risk of outcomes. Sci Rep. 2021;11:11681.","journal-title":"Sci Rep."},{"key":"7943_CR35","doi-asserted-by":"crossref","unstructured":"Chen Yi Mei SLG, Thompson AJ, Christensen B, et al. Sustained virological response halts fibrosis progression: a long-term follow-up study of people with chronic hepatitis C infection. PLoS ONE. 2017;12:e0185609.","DOI":"10.1371\/journal.pone.0185609"},{"key":"7943_CR36","first-page":"17654","volume":"8","author":"Y Wang","year":"2015","unstructured":"Wang Y, Fan Q, Wang T et al. Controlled attenuation parameter for assessment of hepatic steatosis grades: a diagnostic meta-analysis. Int J Clin Exp Med. 2015;8:17654\u201317663.","journal-title":"Int J Clin Exp Med."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-023-07943-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-023-07943-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-023-07943-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T04:35:43Z","timestamp":1684211743000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-023-07943-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,18]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["7943"],"URL":"https:\/\/doi.org\/10.1007\/s10620-023-07943-z","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,18]]},"assertion":[{"value":"21 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare nothing to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}